Subsequent analysis of gene expression identified FGFR4 as the most significant eQTL of the risk allele rs353491-G in both myometrium (log-fold-change = 0.32, P = 0.008) and tumour RNA-seq (log-fold-change = 0.27, P = 0.004). This evidence concerns the gene FGFR4 and neoplasm.